{"mainPropery":{"diseaseId":9373,"diseaseName":"Plasma cell leukemia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9373/plasma-cell-leukemia","synonyms":["Leukemia, plasma cell"],"synonyms-with-source":[{"name":"Leukemia, plasma cell"}],"identifiers":[{"identifierType":"UMLS","identifierId":"C0023484"}]},"diseaseCategories":[{"diseaseTypeId":1,"diseaseTypeName":"Rare Cancers"}],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=%28plasma%5BTitle%5D%20AND%20cell%5BTitle%5D%20AND%20leukemia%5BTitle%5D%29%20AND%20hasabstract%5Btext%5D%20AND%20%222001/05/23%2009.26%22%5BPDAT%5D%20%3A%20%222006/05/23%2009.26%22%5BPDAT%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Plasma cell leukemia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Plasma+cell+leukemia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Plasma cell leukemia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.medscape.com/viewarticle/731900_1' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1543,"resourceId":2171,"resourceName":"National Cancer Institute","descriptionText":"The <a href='http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/Patient' target='_blank'>National Cancer Institute</a> provides the most current information on cancer for patients, health professionals, and the general public.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2160,"resourceId":3368,"resourceName":"Patient Access Network Foundation","descriptionText":"<a href='https://panfoundation.org/index.php/en/patients/assistance-programs/multiple-myeloma' target='_blank'>Patient Access Network Foundation</a> (PAN Foundation) has Assistance Programs for those with health insurance who reside in the United States. The disease fund status can change over time, so you may need to check back if funds are not currently available.&nbsp;","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":7319,"questionText":"What is plasma cell leukemia?","answerText":"Plasma cell leukemia (PCL) is a rare and aggressive form of multiple myeloma that&nbsp;involves high levels of plasma cells circulating in the peripheral blood.&nbsp;The signs and symptoms of PCL include&nbsp;aggressive clinical features, such as extramedullary disease, bone marrow failure, advanced stage disease and expression of distinct immunophenotypic markers.[7202] Different types of treatments are available for patients with&nbsp;PCL.&nbsp;Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. For detailed information on the available treatment options, please visit the following link. <a href=\"http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/Patient/page4\">http://www.cancer.gov/cancertopics/pdq/treatment/myeloma/Patient/page4</a>","dateModified":"2014-02-20T14:30:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":13446,"relatedDiseaseName":"Plasmacytoma","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Plasma_cell_leukemia"}